In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

Ethan Grimes, BS, and Paul Morgan, MD, conduct rational drug design at the newly launched AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai. As part of Mount Sinai ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa. Click here to read an ...

University of California, Los Angeles (UCLA) scientists made the breakthrough after narrowing down drug candidates to two viable compounds. Further research revealed that one of these drugs ...

Research shows that these drugs can inhibit the accumulation of amyloid-beta and may slow cognitive decline during early Alzheimer’s. However, until now, scientists have not investigated whether ...

“Blinding” describes a study design in which knowledge of treatment group (drug vs control) is withheld from relevant individuals involved in the conduct of the study. Imagine that you are a ...

March 19 (UPI) --Two former Colombian Navy cadets have been extradited to the United States to stand trial for allegedly recruiting active Navy personnel to smuggle drugs into the country.

Once in urine, the drug creates visual contrast in the ureters that would otherwise not exist, and using a near-infrared (NIR) camera, surgeons can find the ureters and assess their function in ...

Researchers from the University of Texas Health Science Center at San Antonio have developed a drug that more than doubled ... glioblastoma during a clinical trial. Patients who received the ...